Sunstar Kabushiki Kaisha

Other

501 Sunstar Kabushiki Kaisha

502 Toray Industries, Inc.

Kunio Sugihara

Yasuhiro Katsuragi

Kenji Aimoto

Yasuo Sakano

Mitsunobu Sato

Kenji Hasegawa

Shunichi Hayashi

Satoru Kondo

Takeshi Kikutani

Kouhei Akimoto

Teruko Haguri

A grip member has a grip proper (,) made of a shape-memory resin in the shape of a bar, a connecting pin (,) disposed in one terminal part of the grip proper, a forked part (,) formed integrally in the other terminal side of the grip proper, and an annular part (,) formed integrally slightly toward one end of the grip proper (,) and adapted for enabling the forked part (,) to twine thereon. The grip member is enabled to cope easily with a delicate change in the gripping condition by heating the grip proper (,) and the vicinity thereof to a temperature surpassing the glass transition point of the shape-memory resin thereby endowing the shape-memory rubber with a rubbery state, causing the forked part (,) to twine itself around the annular part (,) in such a manner as to impart the shape of a loop to the grip proper.

Grip member, toothbrush using the grip member and western tableware using the grip member

A pharmaceutical composition for treating viral diseases, such as pasta, gargle, gel, ointment, suppository, spray, etc., containing interferon in a stable state which comprises an effective amount of human interferon, 15 to 60% by weight of a tri or higher polyhydric sugar alcohol and an organic acid buffer as stabilizers, and a conventional pharmaceutical carrier or diluent. The pH of the composition is about 3 to 6. Optionally, the composition can further contain as a stabilizer an anionic surfactant and/or albumin.

Pharmaceutical composition containing interferon in stable state

A pharmaceutical composition for treating erythematodes, particularly, lupus erythematodes discoides, or mycosis, particularly, candidasis, by topical or local administration which comprises an effective amount of human interferon, a trihydric or more higher polyhydric sugar alcohol, an organic acid buffer and, optionally, an anionic surfactant and albumin, and a conventional pharmaceutical carrier or diluent. A method for treating a human subject suffering from erythematodes and mycosis by using this composition is also provided.

Composition and method for treating erythematodes and mycosis

A pharmaceutical composition for treating keratosic disorders of skin and mucosa, particularly, lichen planus and leukoplakia, by topical or local administration which comprises an effective amount of human interferon, a trihydric or more higher polyhydric sugar alcohol, an organic acid buffer and, optionally, an anionic surfactant and albumin, and a conventional pharmaceutical carrier or diluent. A method for treating a human subject suffering from keratosic disorders of skin and mucosa by using this composition is also provided.

Composition and method for treating keratosic disorder of skin and mucosa

Growing community of inventors

Otsu, Japan

Kunio Sugihara